Updated:
Octave Ventures
Octave Ventures makes venture investments in primarily biotech and deep tech companies. Michael S. Kim founded Octave Ventures (US) in 2018. The firm’s...
Octave Ventures
Octave Ventures makes venture investments in primarily biotech and deep tech companies. Michael S. Kim founded Octave Ventures (US) in 2018. The firm’s investments include companies in deep tech and biotech therapeutics.
General information
Firm type
Venture Capital
Year founded
2020
Location
Region
North America
Country
United States
City
Henderson
Corporate office
Henderson, NV, United States
Principals
Michael S. Kim
Founder & CEO
Joshua Schwab
Partner & COO
Sector focus
Frequently asked questions
Where does the firm's investment capital come from?
The source of investment capital for Octave Ventures has not been publicly disclosed. The firm does not list any limited partners, general partners, or wealth-origin narrative on its website or captured Altss sources. This absence of disclosure makes it impossible to attribute the capital to a specific family, institution, or pooled fund structure.
How does Octave Ventures source its pre-IPO deal flow?
The firm's sourcing model is not documented in any captured public materials. There are no named deal partners, operating advisors, or network affiliations disclosed. It is unknown whether the firm relies on proprietary networks, intermediary introductions, or inbound company applications to build its pipeline.
Has Octave Ventures led any known funding rounds recently?
No verifiable investment events or funding-round participation can be traced to Octave Ventures from the last 24 months. The firm does not publish press releases or investment announcements, and no portfolio company disclosures cross-reference Octave Ventures as an investor during the review period.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: